Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.


Journal Article

Alzheimer's disease (AD) is associated with regional reductions in fluorodeoxyglucose positron emission tomography (FDG PET) measurements of the cerebral metabolic rate for glucose, which may begin long before the onset of histopathological or clinical features, especially in carriers of a common AD susceptibility gene. Molecular evaluation of cells from metabolically affected brain regions could provide new information about the pathogenesis of AD and new targets at which to aim disease-slowing and prevention therapies. Data from a genome-wide transcriptomic study were used to compare the expression of 80 metabolically relevant nuclear genes from laser-capture microdissected non-tangle-bearing neurons from autopsy brains of AD cases and normal controls in posterior cingulate cortex, which is metabolically affected in the earliest stages; other brain regions metabolically affected in PET studies of AD or normal aging; and visual cortex, which is relatively spared. Compared with controls, AD cases had significantly lower expression of 70% of the nuclear genes encoding subunits of the mitochondrial electron transport chain in posterior cingulate cortex, 65% of those in the middle temporal gyrus, 61% of those in hippocampal CA1, 23% of those in entorhinal cortex, 16% of those in visual cortex, and 5% of those in the superior frontal gyrus. Western blots confirmed underexpression of those complex I-V subunits assessed at the protein level. Cerebral metabolic rate for glucose abnormalities in FDG PET studies of AD may be associated with reduced neuronal expression of nuclear genes encoding subunits of the mitochondrial electron transport chain.

Full Text

Cited Authors

  • Liang, WS; Reiman, EM; Valla, J; Dunckley, T; Beach, TG; Grover, A; Niedzielko, TL; Schneider, LE; Mastroeni, D; Caselli, R; Kukull, W; Morris, JC; Hulette, CM; Schmechel, D; Rogers, J; Stephan, DA

Published Date

  • March 18, 2008

Published In

Volume / Issue

  • 105 / 11

Start / End Page

  • 4441 - 4446

PubMed ID

  • 18332434

Pubmed Central ID

  • 18332434

Electronic International Standard Serial Number (EISSN)

  • 1091-6490

Digital Object Identifier (DOI)

  • 10.1073/pnas.0709259105


  • eng

Conference Location

  • United States